BDX Q3 2022 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q3 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.6B+0.7% YoY

Gross Profit

$2.1B44.5% margin

Operating Income

$537M11.6% margin

Net Income

$360M7.8% margin

EPS (Diluted)

$1.18

QoQ Revenue Growth

-2.3%

Cash Flow

Operating Cash Flow

$544M

Free Cash Flow

$301M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$53.2B

Total Liabilities

$27.7B

Stockholders' Equity

$25.5B

Cash & Equivalents

$2.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.6B	$4.6B	+0.7%
Gross Profit	$2.1B	$2.0B	+5.6%
Operating Income	$537M	$492M	+9.1%
Net Income	$360M	$525M	-31.4%

Revenue Segments

Medical

$2.2B47%

Life Sciences

$1.3B28%

Interventional

$1.1B25%

Geographic Segments

UNITED STATES

$2.6B57%

Non-US

$2.0B43%